Hepatitis Completed Phase 2 Trials for Ribavirin (DB00811)

Also known as: Hepatits / Hepatitis NOS / Hepatitis, unspecified / Hepatitis nonspecific / Nonspecific hepatitis

IndicationStatusPhase
DBCOND0013077 (Hepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00901524ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVTreatment
NCT00088504Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis CTreatment